The ROI on antibiotics is much lower than that of a "lifetime drug" such as an anti-depressant that a patient will take for years and years. Pharmaceuticals are mostly privatized and that's not changing, so the government is going to have to find some ways to incentivize innovation in the antibiotics market. Counting on government isn't a popular option these days, but this is the perfect role for them actually.